Abbott and St. Jude to sell products to Terumo

SHARE Abbott and St. Jude to sell products to Terumo
abbotthq070114_3.jpg

Abbott Laboratories and St. Jude Medical Inc. have agreed to sell portions of their businesses to medical device maker Terumo Corp. for $1.12 billion in hopes that it will clear the way for their buyout deal. | File photo

Abbott Laboratories and St. Jude Medical Inc. have agreed to sell portions of their businesses to medical device maker Terumo Corp. for $1.12 billion in hopes that it will clear the way for their buyout deal.

North Chicago-based Abbott is buying St. Paul, Minnesota-based St. Jude for $19.3 billion, but the deal faces scrutiny by antitrust regulators. The medical device makers are shedding some units and products to meet regulatory approval for the deal to close.

The sale to Japan-based Terumo includes St. Jude’s Angio-SealT and FemosealT vascular closure products and Abbott’s Vado Steerable Sheath. Abbott will retain its vascular closure products, which include the Perclose ProGlide Suture-Mediated Closure System, StarClose SE Vascular Closure System and Prostar XL Percutaneous Vascular Surgical System.

Abbott expects the St. Jude buyout to close in the fourth quarter.

The Latest
Two train passengers and one person in the truck were killed, according to the Missouri State Highway Patrol.
Devastated survivors struggle to grieve as the deceased’s great-granddaughter calls attention to herself.
The winner of the primary will determine whether the state GOP continues as a center-right party in Illinois or gets recast as a subsidiary of former President Donald Trump.
Women conspire to fool a wealthy but picky bachelor in the Regency romance lush with lovely scenery and good-looking people.